TMCI

What one share of Treace Medical Concepts holds

Surgical and Medical Instruments and Apparatus

We are a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which we estimate 1.1 million are annual surgical candidates.

Treace Medical Concepts’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$3.20
Profit−$0.93
Capex (buildings and equipment)$0.16
Free cash flow−$0.39
Cash and investments$0.70
Debt$0.91
Book value$1.04

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2019$1.07−$0.13$0.03−$0.24—$0.09
2020$1.55−$0.12$0.03−$0.15—$0.02
2021$1.95−$0.43$0.06−$0.41—$1.72
2022$2.57−$0.77$0.27−$0.82—$1.09
2023$3.08−$0.81$0.19−$0.76—$2.23
2024$3.37−$0.90$0.19−$0.79—$1.81
2025$3.36−$0.93$0.21−$0.47—$1.37

Common questions about Treace Medical Concepts

How much does one share of Treace Medical Concepts earn?

Over the last 12 months, Treace Medical Concepts lost $0.93 for each share on $3.20 of sales.

Does Treace Medical Concepts pay a dividend?

Treace Medical Concepts didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Treace Medical Concepts’s book value per share?

Treace Medical Concepts’s book value is $1.04 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Treace Medical Concepts have?

Each share of Treace Medical Concepts has $0.70 of cash and investments and $0.91 of debt, as of June 30, 2026.

What is Treace Medical Concepts’s free cash flow per share?

−$0.39 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Treace Medical Concepts bought back shares?

Treace Medical Concepts’s share count rose about 71% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.